What is Aclaris Therapeutics's deferred revenue?

Aclaris Therapeutics (ACRS) reported deferred revenue of $3.97M in Q1 2026.

How has Aclaris Therapeutics's deferred revenue changed year-over-year?

Aclaris Therapeutics's deferred revenue increased by 2.2% year-over-year, from $3.89M to $3.97M.

What does deferred revenue mean?

Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.

Aclaris Therapeutics ACRS Deferred Revenue

Deferred Revenue at other companies

Kymera TherapeuticsKYMR

$0-100%

CytomX TherapeuticsCTMX

$17.88M-46.2%

Protagonist TherapeuticsPTGX

$6.28M-23.2%

Arcus BiosciencesRCUS

$34M-52.8%

Alumis Inc.ALMS

$6.33M—

Janux TherapeuticsJANX

$37.59M—

Other financials

Income statement

See full

Revenue$2.0M+37.2%

Gross profit$1.6M+68.7%

Operating income-$22.2M-22.7%

Net income-$19.8M-31.4%

EPS (diluted)-$0.15-25.0%

Balance sheet

See full

Cash & equivalents$28.7M-5.6%

Total debt$2.0M-20.1%

Total equity$143.6M-0.3%

Total assets$198.7M+0.3%

Cash flow

See full

Operating cash flow-$18.1M-39.0%

CapEx$13.0K-69.8%

Free cash flow-$18.2M-38.6%

Valuation

See full

Market cap$685.75M+337%

Enterprise value$659.07M+410%

P/S82×+73.1×

Profitability

See full

Gross margin76.3%-9.7pp

Operating margin-961.9%+259pp

Net margin-832.6%+132pp

FCF margin-624.9%—

Returns & leverage

See full

Return on equity-48.4%-15.4pp

Debt / equity0×0.0×

Current ratio4×-1.0×

Where this comes from

Reported directly by Aclaris Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.

The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aclaris Therapeutics's deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aclaris Therapeutics's deferred revenue?: Aclaris Therapeutics (ACRS) reported deferred revenue of $3.97M in Q1 2026.
How has Aclaris Therapeutics's deferred revenue changed year-over-year?: Aclaris Therapeutics's deferred revenue increased by 2.2% year-over-year, from $3.89M to $3.97M.
What does deferred revenue mean?: Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.